Medicare Enrolled
Dr. Peter Morcos, MD
Cardiovascular Disease · La Mesa, CA
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Morcos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morcos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Morcos
Dr. Peter Morcos is a cardiovascular disease specialist in La Mesa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Morcos performed 2,704 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Morcos received a total of $4,962 from 33 pharmaceutical and/or device companies across 252 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Morcos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 43% volume in CA
$4,962 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,704
Medicare services
Top 43% in CA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
511 | $97 | $421 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
402 | $7 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $90 | $227 |
| Heart muscle strain imaging | 202 | $29 | $154 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
155 | $12 | $52 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
116 | $43 | $203 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
114 | $33 | $138 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
107 | $137 | $414 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $137 | $425 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
86 | $6 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
80 | $65 | $167 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
64 | $98 | $243 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
54 | $8 | $37 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
47 | $8 | $53 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
46 | $107 | $311 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
41 | $36 | $163 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
36 | $58 | $261 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
27 | $87 | $401 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $61 | $143 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
21 | $21 | $93 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
21 | $203 | $776 |
| 3D ultrasound of heart for congenital heart defects This procedure uses three-dimensional ultrasound imaging to evaluate the structure of the heart during an assessment for congenital heart defects. |
19 | $20 | $241 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
17 | $20 | $45 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
16 | $25 | $79 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
14 | $21 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
12 | $12 | $40 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $143 | $464 |
| New patient office visit, complex (60-74 min) | 11 | $186 | $598 |
| Blood pressure self-monitoring education Training on how to measure your own blood pressure at home. This service teaches the proper technique for using a home blood pressure monitor. |
11 | $10 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.5% high complexity
24.1% medium
54.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,962
Total received (2018-2024)
Avg $709/year across 7 years
Top 41% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
252
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$285
2023
$347
2022
$160
2021
$58
2020
$299
2019
$1,514
2018
$2,299
Payments by company (2024)
Alnylam Pharmaceuticals Inc.
$50
Amgen Inc.
$32
Boston Scientific Corporation
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Abbott Laboratories
$25
Kestra Medical Technology Services, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$23
iRhythm Technologies, Inc.
$22
Esperion Therapeutics, Inc.
$16
CVRx, Inc.
$15
Baxter Healthcare
$14
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$826
Amgen Inc.
$625
PFIZER INC.
$624
Janssen Pharmaceuticals, Inc
$334
Medtronic Vascular, Inc.
$293
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$244
AstraZeneca Pharmaceuticals LP
$217
GlaxoSmithKline, LLC.
$213
E.R. Squibb & Sons, L.L.C.
$170
Abbott Laboratories
$151
SANOFI-AVENTIS U.S. LLC
$137
Allergan Inc.
$121
Boston Scientific Corporation
$117
iRhythm Technologies, Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Philips Electronics North America Corporation
$87
Regeneron Healthcare Solutions, Inc.
$77
Actelion Pharmaceuticals US, Inc.
$60
Amarin Pharma Inc.
$59
Alnylam Pharmaceuticals Inc.
$50
BIOTRONIK INC.
$48
Kowa Pharmaceuticals America, Inc.
$46
Gilead Sciences, Inc.
$46
Novo Nordisk Inc
$35
Esperion Therapeutics, Inc.
$34
Baxter Healthcare
$33
Kestra Medical Technology Services, Inc.
$25
Antares Pharma, Inc.
$21
W. L. Gore & Associates, Inc.
$19
Shire North American Group Inc
$17
Sunovion Pharmaceuticals Inc.
$16
CVRx, Inc.
$15
SANOFI PASTEUR INC.
$15
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMVUTTRA · ANORO · Aimovig · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · CardioMEMS HF System · Confirm Rx · Connect HF · Corlanor · ELIQUIS · ENTRESTO · FLUZONE HIGH-DOSE · GENERAL - BRADY · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · JARDIANCE · LATITUDE · LEQVIO · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · NEXLETOL · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · SHINGRIX · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRELEGY ELLIPTA · UPTRAVI · UTIBRON · VYNDAQEL · Vascepa · WATCHMAN FLX · XARELTO · XIIDRA · XYOSTED · ZIO Patch · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
224
County median income
$102,285
Nearest hospital to ZIP centroid (approximate)
GROSSMONT HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Morcos is a cardiac & cardiac specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Morcos experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Morcos performed 511 echocardiogram, transthoracic services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Morcos receive payments from pharmaceutical companies?
Yes. Dr. Morcos received a total of $4,962 from 33 companies across 252 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morcos's costs compare to other cardiologists in La Mesa?
Dr. Morcos's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morcos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in La Mesa
Browse cardiologists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology